Larson D L, Portoghese P S
J Med Chem. 1976 Jan;19(1):16-9. doi: 10.1021/jm00223a004.
The brain levels of meperidine and three N-alkyl homologues were determined at equal analgetic iv doses in mice. The relative levels of the four compounds in brain were found to be closely proportional to their ED50 doses even though the compounds exhibit a wide range in partition coefficient and metabolic N-dealkylation. While lipid solubility and metabolism are undoubtedly important factors in the overall time-course brain levels, it appears that during the period of analgetic measurement (5-60 min after injection) these factors do not profoundly affect the relative brain levels because peak uptake occurs within the first 5 min after administration of the homologues. As a consequence, the observed ED50 potencies appear to provide a fair approximation of the relative receptor affinities of the four homologues. N-Dealkylation was observed as a major metabolic transformation by mouse liver in vivo for all four compounds, and the extent of this N-dealkylation was found to directly correspond to the rates of N-dealkylation by mouse liver homogenate seen in an earlier study.
在小鼠中,以相等的镇痛静脉注射剂量测定了哌替啶及其三种N - 烷基同系物的脑内水平。尽管这四种化合物在分配系数和代谢性N - 脱烷基化方面表现出很大差异,但发现它们在脑中的相对水平与它们的半数有效剂量(ED50)密切相关。虽然脂溶性和代谢无疑是影响脑内药物水平总体时间进程的重要因素,但在镇痛测量期间(注射后5 - 60分钟),这些因素似乎并未对相对脑内水平产生深远影响,因为同系物给药后的前5分钟内就出现了峰值摄取。因此,观察到的ED50效价似乎能合理地近似这四种同系物的相对受体亲和力。在体内,小鼠肝脏将所有四种化合物的N - 脱烷基化作为主要的代谢转化过程,并且发现这种N - 脱烷基化的程度与早期研究中观察到的小鼠肝脏匀浆的N - 脱烷基化速率直接相关。